I

    INVO Fertility, Inc. (IVF)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.03
    +0.03 (+3.00%)

    Market Cap: $2.51M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    36%(5/14)
    Avg Surprise
    -672.96%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-5.20
    Range$-5.20 - $-5.20
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-5.20
    Revenue Consensus
    $3M
    Range$3M - $3M
    1 analysts
    Dec 31, 2026
    EPS Consensus$-2.40
    Range$-2.40 - $-2.40
    1 analysts
    Revenue Consensus
    $3M
    Range$3M - $3M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-2.40---
    Sep 26EST
    		-$-5.20---
    Jun 26
    		$0.35N/A+106.25%Beat+104.3%
    Mar 26
    		$-3.38N/A+66.20%Beat+99.7%
    Dec 25
    		$N/A$-22.00N/ABeat-
    Sep 25
    		$-0.77$0.00N/ABeat+99.9%
    Jun 25
    		$-8.07$0.00N/ABeat+99.1%
    Mar 25
    		$-1084.80$-420.00-158.29%Miss-79.4%
    Dec 24
    		$-1084.80$-420.00-158.29%Miss-154871.5%
    Sep 24
    		$-604.26N/AN/ABeat-19647.1%
    Jun 24
    		$-895.63N/AN/ABeat-389303.0%
    Mar 24
    		$-604.70N/AN/ABeat-287850.3%
    Sep 23
    		$-0.70N/A+68.18%Beat+84.8%
    Jun 23
    		$-3.06$-3.20+4.38%Beat+33.5%
    Mar 23
    		$-0.23$-0.19-21.05%Miss-215.0%
    Sep 22
    		$-0.21$-0.12-75.00%Miss+95.6%
    Jun 22
    		$-4.60$-0.24-1816.67%Miss-35.3%
    Mar 22
    		$-4.60$-0.25-1740.00%Miss+8.0%
    Dec 21
    		$0.20$-0.22+192.29%Beat+102.1%
    Sep 21
    		$-4.80$-0.20-2300.00%Miss+33.3%
    Jun 21
    		$-3.40$-0.19-1689.47%Miss-1900.0%
    Mar 21
    		$-5.00$-0.25-1900.00%Miss-2677.8%
    Dec 20
    		$-9.50$0.00N/AMiss+91.5%
    Sep 20
    		$-7.20N/AN/ABeat+93.2%
    Jun 20
    		$-0.17N/AN/ABeat+99.5%
    Mar 20
    		$-0.18N/AN/ABeat-1700.0%
    Dec 19
    		$-111.59N/AN/ABeat+97.6%
    Sep 19
    		$-105.20N/AN/ABeat-128.3%
    Jun 19
    		$-35.85N/AN/ABeat-358352.0%
    Mar 19
    		$-0.01N/AN/ABeat+100.0%
    Dec 18
    		$-4698.74N/AN/ABeat-258.9%
    Sep 18
    		$-46.07N/AN/ABeat+95.3%
    Jun 18
    		$-0.01N/AN/ABeat+100.0%
    Mar 18
    		$-23.26N/AN/ABeat+98.3%
    Dec 17
    		$-1309.33N/AN/ABeat+27.7%
    Sep 17
    		$-970.31N/AN/ABeat+29.8%
    Jun 17
    		$-893.50N/AN/ABeat-
    Mar 17
    		$-1406.98N/AN/ABeat-
    Dec 16
    		$-1811.84N/AN/ABeat-
    Sep 16
    		$-1381.92N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.09EV/EBITDA-1.24x
    Price/FCF-0.51xFCF Yield-194.39%
    Profitability
    Profit Margin-70.20%Operating Margin-59.30%
    ROE-55.30%ROIC-66.14%
    Financial Health
    Debt/Equity0.09xInterest Coverage-10.73x
    Current Ratio0.71xQuick Ratio0.67x
    Trading Statistics
    BetaN/AAvg Volume6.31M
    52-Week High$56.0052-Week Low$0.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.10
    SMA 20$1.09
    SMA 50$1.19
    SMA 200$3.89
    EMA 10$1.06
    EMA 20$1.08
    EMA 50$1.25
    EMA 200$25.02

    MACD

    Line: -0.03Signal: -0.03Hist: -0.00

    ADX

    ADX: 34.6+DI: 47.3-DI: 16.1

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down8.0
    PSAR$2.12

    Bollinger Bands

    Upper Band$1.37
    Lower Band$0.80
    %B Position5214%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    45.9

    Momentum Oscillators

    Stoch %K3.6
    Stoch %D4.3
    Williams %R-95.9
    ROC (10d)-32.7%
    Momentum-0.50
    CCI (20d)-51.5
    MFI (14d)95.7

    Volatility Measures

    ATR (14d)$0.18(17.1%)
    StdDev (20d)0.14
    Hist Vol229.5%(High)

    Volume Flow

    VWAP$1.02
    OBV949.2M
    AD Line275.3B
    CMF (20d)-0.792

    Volume Metrics

    Avg Vol (20d)6.6M
    Vol Ratio0.0x(Low)
    VWMA (20d)$1.50

    Pivot Points

    R3$1.07
    R2$1.05
    R1$1.03
    Pivot Point$1.01
    S1$0.99
    S2$0.97
    S3$0.95

    Advanced Oscillators

    TSI-5.74
    Ultimate Osc29.9
    KST2.10

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.18M$2.02M$1.58M$1.76M$1.86M$1.64M$1.69M$1.43M$1.84M$1.58M$1.38M$974,894
    Cost of Revenue$1.56M$1.29M$1.05M$1.13M$1.09M$1.04M$957,419$988,465$861,648$850,234$886,750$580,968
    Gross Profit$617,100$727,826$536,860$629,345$770,051$592,256$728,547$444,686$974,949$726,052$495,004$393,926
    Operating Expenses$1.91M$2.32M$3.00M$2.26M$2.36M$3.05M$4.70M$1.75M$2.88M$1.67M$2.00M$1.28M
    R&D$0$0$0$0$0$265,663$484,780$171,224$0$4,880$5,907$2,668
    SG&A$0$2.18M$1.81M$2.13M$2.19M$2.55M$3.48M$1.51M$2.65M$1.44M$1.86M$1.26M
    Operating Income$-1,289,650$-1,590,971$-1,412,256$-1,635,484$-1,592,735$-2,462,343$-3,975,807$-1,300,402$-1,902,913$-946,374$-1,508,468$-886,290
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$177,227$180,323$627,107$145,803$221,325$311,270$231,824$273,629$369,612$181,295$182,043$352,085
    Income Before Tax$944,894$-5,539,351$1.86M$-2,644,625$-3,209,094$-17,403,586$-3,677,501$-1,601,403$-2,245,170$-1,594,677$-1,971,747$-1,246,554
    Income Tax Expense$56,154$-150,371$0$0$0$0$-54,008$29,259$0$1,836$23,035$1,886
    Net Income$888,740$-5,539,351$2.01M$-2,644,625$-5,284,858$-17,403,586$-3,623,493$-1,630,662$-2,245,170$-1,596,513$-1,994,782$-1,248,440
    EBITDA$-1,144,077$-5,216,330N/A$-2,362,081$-2,818,032$-16,857,854$-3,213,867$-1,097,279$-1,645,220$-1,186,419$-1,648,102$-873,969
    EBIT$-1,289,650$-5,359,028N/A$-2,498,822$-2,987,769$-17,092,316$-3,445,677$-1,327,774$-1,875,558$-1,413,379$-1,789,700$-894,473
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IVF

    News

    INVO Fertility Releases Q2 2026 Financial Results

    INVO Fertility, Inc. (NAYA) reported strong Q2 2026 financial results with diluted earnings of $0.35 per share and revenue of $2.2 million, marking a 17.0% increase year-over-year. The medical device company achieved a net income of $888,740, driven by the commercialization of its INVOcell retention device. The company's business model, focused on placing devices within partner clinics, has led to scalable growth and increased adoption of its cost-effective fertility treatment technology.

    AlphaStreet•8/18/26•
    Neutral

    INVO Fertility Reports 17% Q2 Revenue Growth and $888,740 Net Income

    INVO Fertility (NASDAQ: INVO) announced a 17% increase in second-quarter revenue, reaching $4.8 million, and a net income of $888,740. The company, which specializes in fertility treatment, also reported a significant improvement in adjusted EBITDA, rising to $1.2 million from $0.4 million in the prior year. This positive financial performance is attributed to the expansion of its clinic network and increased adoption of its INVOcell technology.

    Moomoo•8/17/26•
    Neutral

    INVO Fertility: Clinic-Level EBITDA More Than Doubles Sequentially

    INVO Fertility reported that its clinic operations generated approximately $333,000 in Clinic-Level Adjusted EBITDA in Q2 2026, more than double the previous quarter, driven by increased revenue and strategic acquisitions. Despite this clinic-level profitability, the consolidated Adjusted EBITDA loss widened, highlighting the company's strategy to scale operations to absorb corporate expenses. INVO aims to achieve greater scale by evaluating a pipeline of established and profitable U.S. fertility clinics and investing in shared capabilities.

    Pulse 2.0•8/17/26•
    Bullish

    INVO Fertility, Inc. Stock Reverses From $2.80 High as RSI Hits 82

    INVO Fertility, Inc. (IVF) stock experienced a volatile day, reversing from an intraday high of $2.80 to close at $2.03. The stock is considered overbought with daily RSI14 at 78.69 and hourly RSI14 at 82.66, and trades significantly above its daily Bollinger upper band. While short-term momentum is positive, the stock remains in a larger long-term downtrend, with key support at $1.72 and resistance at $2.57.

    Bitget•8/17/26•
    Somewhat-Bearish

    INVO Fertility, Inc. Stock Analysis: Overbought Signals Clash with Momentum

    INVO Fertility, Inc. (IVF) stock experienced extreme volatility, reversing sharply from an intraday high of $2.80 to close at $2.03. Technical indicators show the stock is significantly overbought, with high RSI readings on daily and hourly charts, yet short-term momentum remains positive. The article highlights a conflict between overbought signals and ongoing momentum, suggesting potential for a pullback despite short-term bullishness, all within a larger long-term downtrend.

    The Cryptonomist•8/17/26•
    Somewhat-Bearish

    Frequently Asked Questions About IVF

    Does IVF pay dividends?
    INVO Fertility, Inc. (IVF) does not currently pay a regular dividend.
    What is IVF's market cap?
    INVO Fertility, Inc. (IVF) has a market capitalization of $2.51M with a current stock price of $1.03.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In